Armistice Capital LLC Has $16.28 Million Stock Holdings in Crocs, Inc. $CROX

Armistice Capital LLC lifted its stake in Crocs, Inc. (NASDAQ:CROX) by 468.5% during the fourth quarter, Holdings Channel.com reports. The fund owned 190,350 shares of the textile maker’s stock after buying an additional 156,870 shares during the period. Armistice Capital LLC’s holdings in Crocs were worth $16,279,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also bought and sold shares of CROX. Cetera Investment Advisers boosted its position in Crocs by 10.3% during the fourth quarter. Cetera Investment Advisers now owns 25,393 shares of the textile maker’s stock valued at $2,172,000 after purchasing an additional 2,365 shares during the last quarter. Incision Capital Management LP acquired a new position in shares of Crocs during the 4th quarter worth approximately $27,794,000. Trexquant Investment LP acquired a new position in shares of Crocs during the 4th quarter worth approximately $548,000. Amundi bought a new stake in shares of Crocs during the 4th quarter worth approximately $353,000. Finally, Sciencast Management LP raised its stake in shares of Crocs by 100.1% during the 4th quarter. Sciencast Management LP now owns 38,988 shares of the textile maker’s stock worth $3,334,000 after purchasing an additional 19,508 shares in the last quarter. Institutional investors own 93.44% of the company’s stock.

Crocs Stock Performance

Shares of CROX stock opened at $124.53 on Thursday. Crocs, Inc. has a 52 week low of $73.21 and a 52 week high of $129.79. The company has a market capitalization of $6.19 billion, a price-to-earnings ratio of -90.24, a PEG ratio of 1.31 and a beta of 1.57. The company has a 50-day simple moving average of $108.79 and a 200 day simple moving average of $94.31. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.04 and a current ratio of 1.67.

Crocs (NASDAQ:CROX) last released its quarterly earnings results on Thursday, April 30th. The textile maker reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.78 by $0.21. Crocs had a negative net margin of 2.58% and a positive return on equity of 48.29%. The firm had revenue of $921.46 million for the quarter, compared to analysts’ expectations of $900.57 million. During the same period in the prior year, the firm earned $3.00 EPS. The business’s revenue was down 1.7% on a year-over-year basis. Crocs has set its Q2 2026 guidance at 4.150-4.350 EPS and its FY 2026 guidance at 13.200-13.750 EPS. On average, sell-side analysts predict that Crocs, Inc. will post 13.67 earnings per share for the current year.

Insider Buying and Selling

In other Crocs news, CEO Andrew Rees sold 32,688 shares of Crocs stock in a transaction dated Friday, June 5th. The shares were sold at an average price of $118.09, for a total value of $3,860,125.92. Following the completion of the sale, the chief executive officer owned 743,293 shares in the company, valued at $87,775,470.37. The trade was a 4.21% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 3.10% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently weighed in on CROX. Wedbush assumed coverage on shares of Crocs in a research note on Monday, June 8th. They issued an “outperform” rating for the company. Piper Sandler cut shares of Crocs from a “neutral” rating to a “neutral” rating in a research note on Monday, June 8th. The Goldman Sachs Group downgraded shares of Crocs from a “sell” rating to a “neutral” rating in a research report on Monday, June 8th. Stifel Nicolaus upped their target price on shares of Crocs from $105.00 to $125.00 and gave the company a “hold” rating in a report on Monday. Finally, Robert W. Baird upgraded shares of Crocs from a “neutral” rating to an “outperform” rating and raised their target price for the company from $115.00 to $150.00 in a research note on Monday, June 8th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $120.00.

About Crocs

Crocs, Inc is a global footwear designer, developer and distributor best known for its lightweight, proprietary Croslite™ foam-clog construction. The company’s product portfolio encompasses a range of styles, including clogs, sandals, slides, boots and sneakers, all featuring the slip-resistant, odor-resistant and cushion-providing qualities of the Croslite material. Crocs distributes its products through an omnichannel network that includes e-commerce platforms, company-owned retail stores, authorized dealers and wholesale partners.

Founded in 2002 by Scott Seamans, Lyndon “Duke” Hanson and George Boedecker Jr., Crocs launched its first clog on the island of Vail, Colorado.